Teligen and Cognis defibrillators - risks for devices implanted subpectorally

(Boston Scientific) specific models of defibrillators implanted subpectorally have a risk of loss of shock therapy, inappropriate shock therapy, loss of pacing therapy or loss of anti-tachycardia pacing. (MDA/2010/012)